Statement Of Cash Flows [Abstract]

Optomed Oyj - Filing #3684582

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
1 510 EUR
354,000 EUR
Interest paid, classified as operating activities
115,000 EUR
169,000 EUR
Interest received, classified as operating activities
151,000 EUR
0 EUR
Cash flows from (used in) operating activities
1 596 EUR
615,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
275,000 EUR
213,000 EUR
Purchase of intangible assets, classified as investing activities
1 843 EUR
2 199 EUR
Cash flows from (used in) investing activities
2 118 EUR
2 412 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
9 182 EUR
4 310 EUR
Repayments of borrowings, classified as financing activities
1 053 EUR
1 921 EUR
Payments of lease liabilities, classified as financing activities
494,000 EUR
462,000 EUR
Cash flows from (used in) financing activities
7 081 EUR
1 609 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
3 367 EUR
1 419 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
19,000 EUR
13,000 EUR
Cash and cash equivalents
10 467 EUR
7 118 EUR
8 524 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.